These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 6198831)
1. Pharmacological prevention of thrombotic occlusion in arterial reconstructive surgery. Bergqvist D Acta Chir Scand; 1983; 149(8):721-7. PubMed ID: 6198831 [No Abstract] [Full Text] [Related]
2. Are agents affecting platelet functions clinically useful? Verstraete M Am J Med; 1976 Dec; 61(6):897-914. PubMed ID: 795299 [TBL] [Abstract][Full Text] [Related]
3. Antiplatelet drugs in the management of patients with thrombotic disorders. Harker LA Semin Thromb Hemost; 1986 Apr; 12(2):134-55. PubMed ID: 3016905 [No Abstract] [Full Text] [Related]
4. Prevention of early reocclusion by dipyridamole and ASA in arterial reconstructive surgery. Harajola PT; Meurala H; Frick MH J Cardiovasc Surg (Torino); 1981; 22(2):141-4. PubMed ID: 7014570 [TBL] [Abstract][Full Text] [Related]
5. [Platelet function inhibitors in peripheral arteriopathies]. Strano A; Davì G; Cannizzaro S; Giubilato A Recenti Prog Med; 1986 Apr; 77(4):205-9. PubMed ID: 2872704 [No Abstract] [Full Text] [Related]
6. Current treatment for thrombotic diseases. Cazenave JP; Wiesel ML; Hemmendinger S Agents Actions Suppl; 1984; 15():24-49. PubMed ID: 6091424 [No Abstract] [Full Text] [Related]
7. [New possibilities in the prevention of thrombosis]. Kummer H Schweiz Rundsch Med Prax; 1973 May; 62(20):619-25. PubMed ID: 4702970 [No Abstract] [Full Text] [Related]
8. [Effect of antiplatelet therapy on prevention of thrombotic diseases]. Mase K; Yasunaga K Nihon Naika Gakkai Zasshi; 1991 Jun; 80(6):891-6. PubMed ID: 1833490 [No Abstract] [Full Text] [Related]
10. [Prevention of thrombosis with coumarin, low doses of heparin, dextran and inhibitors of platelet function]. Loeliger EA Ned Tijdschr Geneeskd; 1977 Oct; 121(44):1748-54. PubMed ID: 335258 [No Abstract] [Full Text] [Related]
11. [Peripheral arterial revascularization: which antithrombotic agents?]. Haulon S; Susen S; Koussa M; Jude B Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1278-84. PubMed ID: 11794970 [TBL] [Abstract][Full Text] [Related]
12. [Postoperative antithrombotic therapy in acute occlusion of the major arteries of the extremities]. Il'in VN; Stepanov NV; Ikhaev ZA; Sharonin GV; Bogdanets LI Vestn Khir Im I I Grek; 1980 Sep; 125(9):7-13. PubMed ID: 6158785 [TBL] [Abstract][Full Text] [Related]
13. Management of thrombotic diseases. Douglas AS Semin Hematol; 1971 Apr; 8(2):95-139. PubMed ID: 4396057 [No Abstract] [Full Text] [Related]
16. Antiplatelet drugs or dicoumarol: what is the most effective prophylaxis in occlusive arterial disease? Poliwoda H; Avenarius HJ Int Angiol; 1986; 5(3):169-80. PubMed ID: 2435823 [TBL] [Abstract][Full Text] [Related]
17. [Prophylaxis of thrombotic complications of reconstructive interventions for occlusion of the main arteries of femoral-popliteal segment]. Nikul'nikov PI; Ratushniuk AV; Guch AA Klin Khir; 2008 Jul; (7):24-7. PubMed ID: 19048816 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of experimental arterial thrombosis in dogs with platelet-deaggregating agents. Danese CA; Haimov M Surgery; 1971 Dec; 70(6):927-34. PubMed ID: 5124672 [No Abstract] [Full Text] [Related]
19. [Thrombosis prevention and treatment in pediatrics]. Weissbach G Z Gesamte Inn Med; 1979 Jan; 34(1):35-40. PubMed ID: 373278 [No Abstract] [Full Text] [Related]
20. [Administration of dalteparin in reconstructive vascular surgery]. Pokrovskiĭ AV; Gontarenko VN; Titova MI Angiol Sosud Khir; 2011; 17(2):17-22. PubMed ID: 21983457 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]